RxFunction Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
88
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$16.5M
- Investors
-
3
RxFunction General Information
Description
Developer of an assistive medical device designed to provide balance to people with peripheral neuropathy. The company's device is a shoe insert that measures foot pressure and gives immediate, gentle, and tactile sensory cues to help control balance and stability and restore a person's ability to walk normally after the loss of sensation in the feet, enabling patients to restore balance, increase mobility, and boost confidence.
Contact Information
Website
www.rxfunction.comCorporate Office
- 6509 Flying Cloud Drive
- Suite 140
- Eden Prairie, MN 55344
- United States
Corporate Office
- 6509 Flying Cloud Drive
- Suite 140
- Eden Prairie, MN 55344
- United States
RxFunction Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 14-Oct-2026 | $16.5M | Completed | Generating Revenue | ||
| 8. Later Stage VC | 04-Mar-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 09-Dec-2020 | Completed | Generating Revenue | |||
| 6. Debt - PPP | 07-Apr-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 24-Jan-2019 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 30-Sep-2016 | Completed | Clinical Trials - General | |||
| 3. Grant | 01-Jan-2013 | Completed | Startup | |||
| 2. Angel (individual) | 01-Jan-2012 | $200K | $200K | Completed | Startup | |
| 1. Grant | 01-Jan-2011 | $162K | Completed | Startup |
RxFunction Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
RxFunction Comparisons
Industry
Financing
Details
RxFunction Competitors (7)
One of RxFunction’s 7 competitors is Xuma Medical, a Venture Capital-Backed company based in Singapore, Singapore.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xuma Medical | Venture Capital-Backed | Singapore, Singapore | ||||
| Rocknroo | Corporation | Delft, Netherlands | ||||
| Biotronik | Corporate Backed or Acquired | Berlin, Germany | ||||
| Pediatric Exo | Accelerator/Incubator Backed | Houston, TX | ||||
| ApiFix | Formerly VC-backed | Yokneam Illit, Israel |
RxFunction Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RxFunction Patents
RxFunction Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4583774-A2 | Sensory modulation systems for improving gait function and/or balance control | Pending | 09-Sep-2022 | ||
| EP-4583774-A4 | Sensory modulation systems for improving gait function and/or balance control | Pending | 09-Sep-2022 | ||
| WO-2024054676-A3 | Sensory modulation systems for improving gait function and/or balance control | Inactive | 09-Sep-2022 | ||
| US-20240082004-A1 | Sensory modulation systems for improving gait function and/or balance control and related methods | Pending | 09-Sep-2022 | ||
| WO-2024054676-A2 | Sensory modulation systems for improving gait function and/or balance control and related methods | Inactive | 09-Sep-2022 | A61F2/30721 |
RxFunction Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RxFunction Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MN Investment Bank | Investment Bank | Minority | ||
| National Institutes of Health | Government | |||
| U.S. Department of Health and Human Services | Government |
RxFunction FAQs
-
When was RxFunction founded?
RxFunction was founded in 2010.
-
Where is RxFunction headquartered?
RxFunction is headquartered in Eden Prairie, MN.
-
What is the size of RxFunction?
RxFunction has 88 total employees.
-
What industry is RxFunction in?
RxFunction’s primary industry is Therapeutic Devices.
-
Is RxFunction a private or public company?
RxFunction is a Private company.
-
What is RxFunction’s current revenue?
The current revenue for RxFunction is .
-
How much funding has RxFunction raised over time?
RxFunction has raised $45.6M.
-
Who are RxFunction’s investors?
MN Investment Bank, National Institutes of Health, and U.S. Department of Health and Human Services have invested in RxFunction.
-
Who are RxFunction’s competitors?
Xuma Medical, Rocknroo, Biotronik, Pediatric Exo, and ApiFix are some of the 7 competitors of RxFunction.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
